An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 202020
Company: HORIZON

Summary Review

Products on NDA 202020

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
RAYOS	PREDNISONE	1MG	TABLET, DELAYED RELEASE;ORAL	Discontinued	None	Yes	No
RAYOS	PREDNISONE	2MG	TABLET, DELAYED RELEASE;ORAL	Discontinued	None	Yes	No
RAYOS	PREDNISONE	5MG	TABLET, DELAYED RELEASE;ORAL	Discontinued	None	Yes	No

Approval Date(s) and History, Letters, Labels, Reviews for NDA 202020

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
07/26/2012	ORIG-1	Approval	Type 3 - New Dosage Form	STANDARD	Label (PDF) Letter (PDF) Review Summary Review (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202020s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/202020Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/202020_rayos_toc.cfm https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/202020Orig1s000SumR.pdf

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
06/05/2024	SUPPL-13	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/202020s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/202020Orig1s013ltr.pdf
12/27/2019	SUPPL-12	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202020s012lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/202020Orig1s012ltr.pdf
07/22/2016	SUPPL-10	Manufacturing (CMC)		Label is not available on this site.
02/05/2016	SUPPL-9	Manufacturing (CMC)		Label is not available on this site.
08/12/2014	SUPPL-7	Manufacturing (CMC)		Label is not available on this site.
02/10/2014	SUPPL-6	Manufacturing (CMC)		Label is not available on this site.
05/12/2014	SUPPL-5	Manufacturing (CMC)		Label is not available on this site.
10/25/2013	SUPPL-4	Manufacturing (CMC)		Label is not available on this site.
06/13/2013	SUPPL-3	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/202020s003lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/202020Orig1s003ltr.pdf
03/13/2013	SUPPL-1	Manufacturing (CMC)		Label is not available on this site.

Labels for NDA 202020

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
06/05/2024	SUPPL-13	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/202020s013lbl.pdf
12/27/2019	SUPPL-12	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/202020s012lbl.pdf
06/13/2013	SUPPL-3	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/202020s003lbl.pdf
07/26/2012	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202020s000lbl.pdf

Top